louisiana glp-1 nausea class action Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus glp-1 vomiting law office in

While gastrointestinal side effects remained the most common adverse events, including nausea, vomiting, and diarrhea, the overall safety profile was broadly similar to existing incretin-based therapies

In clinical trials, participants who took the highest dose of the pill lost an average of 16.6 percent of their body weight (approximately 32 pounds for a 200-pound person) after 64 weeks, the drugs manufacturer, Novo Nordisk, said in a Dec

Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19

4 While these trial results are encouraging, it is important to distinguish between relative risk reduction and absolute risk reduction